908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook - Marketscreener.com

2 years ago 35

Delayed Nasdaq  -  04:00 2022-11-11 p.m. EST
16.01 USD   +6.66%

11/14/2022 | 07:02am EST

Q3 2022 gross increases 26% implicit anterior year, with gross borderline of 59%

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop wide spec devices for chemic and biomolecular analysis, contiguous reported fiscal results for the 4th ended September 30, 2022.

“We were pleased with our results for the 3rd 4th arsenic we proceed to enactment our customers’ critical-to-life applications. We besides executed the strategical acquisition of TRACE Analytics, which provides in-line investigating of captious parameters successful the bioreactor and enables america to fast-track improvement of our on-line REBEL technology,” said Kevin J. Knopp, CEO and Co-founder. “During the quarter, we began to spot immoderate slowdown and lengthening of acquisition cycles, successful ample portion owed to macro-economic pressures, which has resulted successful america lowering our expectations for the remainder of the year. Despite near-term headwinds, our squad is focused connected serving our customers, expanding our idiosyncratic base, and making our exertion adjacent much accessible with caller merchandise launches planned for aboriginal 2023.”

Recent Highlights

  • Revenue of $15.8 cardinal for the 3rd 4th of 2022, representing a 26% summation implicit the anterior twelvemonth period
  • Expanded installed basal to 2,317 devices with 175 devices placed during the 3rd quarter
  • Received a $3.1 cardinal bid from the U.S. Army for aerosol modules for the MX908 instrumentality utilized to observe and place vapor and aerosol hazards
  • Demonstrated improved compartment civilization outcomes utilizing the REBEL™ at-line media analyzer, including accrued titer by up to 40% and simplification of toxic metabolite accumulation, successful collaboration with UK-based Center for Process Innovation (CPI)
  • Launched a pesticide people battalion for the MX908® handheld instrumentality developed successful coordination with the U.S. Forest Service, an bureau of the U.S. Department of Agriculture, for harmless and speedy remediation of amerciable marijuana grown connected national lands
  • Hosted yearly idiosyncratic gathering covering the afloat breadth of our level with talks from cardinal sentiment leaders including Boehringer Ingelheim, MIT, Clemson University, Ohio Bureau of Criminal Investigation, and the Fresno Police Department, among others

Third Quarter 2022 Financial Results

Revenue was $15.8 cardinal for the 3 months ended September 30, 2022, a 26% summation implicit the anterior twelvemonth period. This summation was chiefly driven by merchandise gross from an summation successful handheld recurring gross and desktop instrumentality placements. Desktop gross grew 51% twelvemonth implicit twelvemonth due to the fact that of some accrued instrumentality income and accrued recurring revenue.

The installed basal grew to 2,317 placements with 175 devices placed successful Q3 2022.

Gross nett was $9.3 cardinal for the 3rd 4th of 2022, compared to $6.8 cardinal for the corresponding anterior twelvemonth period. Gross borderline was 59%, arsenic compared to 54% for the corresponding anterior twelvemonth period. The summation successful gross borderline was driven by the accrued merchandise and work gross and an summation successful the mean selling terms for devices, offset successful portion by planned investments successful unit and expenses successful calendar twelvemonth 2021 and the archetypal 9 months of 2022.

Operating expenses were $16.5 cardinal for the 3rd 4th of 2022, compared to $12.1 cardinal for the corresponding anterior twelvemonth period. This summation was driven by headcount enlargement crossed our business, an summation successful stock-based compensation, and an summation successful selling activities and question expenses.

Net nonaccomplishment was $6.3 cardinal for the 3rd 4th of 2022, compared to $5.2 cardinal for the corresponding anterior twelvemonth period. Net nonaccomplishment per stock was $0.20 for the 3rd 4th of 2022, compared to a nett nonaccomplishment per stock of $0.19 for the corresponding anterior twelvemonth period.

Cash and currency equivalents were $193.7 cardinal arsenic of September 30, 2022. In addition, the Company had astir $15.0 cardinal of indebtedness outstanding.

2022 Guidance

908 Devices is updating its afloat twelvemonth 2022 gross outlook and present expects gross to beryllium successful the scope of $46 cardinal to $49 million, representing maturation of 13% implicit afloat twelvemonth 2021 astatine the midpoint of the range.

Webcast Information

908 Devices volition big a league telephone to sermon the 3rd 4th 2022 fiscal results earlier marketplace unfastened connected Monday, November 14, 2022 astatine 5:30 americium Pacific Time / 8:30 americium Eastern Time. A webcast of the league telephone tin beryllium accessed astatine https://ir.908devices.com/news-events/events. The webcast volition beryllium archived and disposable for replay for astatine slightest 90 days aft the event.

About 908 Devices

908 Devices is democratizing laboratory wide spectrometry with its elemental handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are utilized astatine the point-of-need to interrogate chartless and invisible materials and supply quick, actionable answers to straight code immoderate of the astir captious problems successful beingness sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered successful the bosom of Boston, wherever it designs and manufactures innovative products that bring unneurotic the powerfulness of wide spectrometry, microfluidic separations, bundle automation, and instrumentality learning.

Forward Looking Statements

This property merchandise includes “forward looking statements” wrong the meaning of the Private Securities Litigation Reform Act of 1995. All statements different than statements of humanities facts are forward-looking statements, including, without limitation, statements regarding the Company’s aboriginal gross and growth. Words specified arsenic “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and akin expressions (as good arsenic different words oregon expressions referencing aboriginal events, conditions oregon circumstances) are intended to place forward-looking statements. These forward-looking statements are based connected management’s existent expectations and impact known and chartless risks, uncertainties and assumptions which whitethorn origin existent results to disagree materially from immoderate results expressed oregon implied by immoderate forward-looking statement, including the risks outlined nether “Risk Factors” and elsewhere successful the Company’s filings with the Securities and Exchange Commission which are disposable connected the SEC's website astatine www.sec.gov. Additional accusation volition beryllium made disposable successful our yearly and quarterly reports and different filings that we marque from clip to clip with the SEC. Although the Company believes that the expectations reflected successful its forward-looking statements are reasonable, it cannot warrant aboriginal results. The Company has nary obligation, and does not undertake immoderate obligation, to update oregon revise immoderate forward-looking connection made successful this property merchandise to bespeak changes since the day of this property release, but arsenic whitethorn beryllium required by law.

908 DEVICES INC.
Condensed Consolidated Statements of Operations
(in thousands, but stock and per stock amounts)
(unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2022

2021

2022

2021

Revenue:

Product and work revenue

$

15,437

$

12,285

$

34,074

$

25,557

License and declaration revenue

360

260

1,135

808

Total revenue

15,797

12,545

35,209

26,365

Cost of revenue:

Product and work outgo of revenue

6,366

5,656

14,768

12,062

License and declaration outgo of revenue

93

77

340

204

Total outgo of revenue

6,459

5,733

15,108

12,266

Gross profit

9,338

6,812

20,101

14,099

Operating expenses:

Research and development

4,666

3,302

12,864

9,322

Selling, wide and administrative

11,826

8,786

32,281

23,318

Total operating expenses

16,492

12,088

45,145

32,640

Loss from operations

(7,154

)

(5,276

)

(25,044

)

(18,541

)

Other income (expense), net

895

91

1,272

(163

)

Net loss

$

(6,259

)

$

(5,185

)

$

(23,772

)

$

(18,704

)

Net nonaccomplishment per stock attributable to communal stockholders

$

(0.20

)

$

(0.19

)

$

(0.76

)

$

(0.68

)

Weighted mean communal shares outstanding

31,606,484

27,707,858

31,411,611

27,446,149

908 DEVICES INC.
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)

September 30,

December 31,

2022

2021

Assets

Current assets:

Cash and currency equivalents

$

193,698

$

224,073

Accounts receivable, net

15,231

16,375

Inventory

11,731

7,918

Prepaid expenses and different existent assets

3,222

4,527

Total existent assets

223,882

252,893

Operating lease, right-of-use assets

4,271

5,182

Property and equipment, net

2,761

1,603

Goodwill

9,200

Intangibles, net

7,969

Other semipermanent assets

1,198

1,228

Total assets

$

249,281

$

260,906

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable and accrued expenses

$

10,227

$

8,332

Deferred revenue

7,419

5,160

Operating lease liabilities

1,432

1,344

Total existent liabilities

19,078

14,836

Long-term debt

15,000

15,000

Deferred revenue, nett of existent portion

12,162

11,958

Other semipermanent liabilities

6,541

4,508

Total liabilities

52,781

46,302

Total stockholders' equity

196,500

214,604

Total liabilities and stockholders' equity

$

249,281

$

260,906

Business Wire 2022

All quality about 908 DEVICES INC.
07:17a908 Devices Inc. : Results of Operations and Financial Condition, Financial Statements and..

AQ

07:05aEarnings Flash (MASS) 908 DEVICES Reports Q3 Revenue $15.8M, vs. Street Est of $15.7M

MT

07:02a908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Out..

BU

11/10908 Devices Records Strong Momentum successful Life Sciences Sector

BU

11/09908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Gr..

BU

11/09908 Devices Inc. Launches Pesticide Identification Capability to Thwart Illegal Marijua..

CI

11/08908 Devices Inc. : Entry into a Material Definitive Agreement, Termination of a Material D..

AQ

11/08908 Devices Inc. Enters Into Loan and Security Agreement

CI

11/02908 Devices to Participate successful Upcoming Investor Conferences

BU

10/19Insider Sell: 908 Devices

MT

Analyst Recommendations on 908 DEVICES INC.

Financials (USD)

Sales 2022 53,6 M - -
Net income 2022 -30,2 M - -
Net Debt 2022 - - -
P/E ratio 2022 -16,5x
Yield 2022 -
Capitalization 506 M 506 M -
Capi. / Sales 2022 9,44x
Capi. / Sales 2023 7,56x
Nbr of Employees 177
Free-Float 91,7%
Chart 908 DEVICES INC.

Duration : Period :

908 Devices Inc. Technical Analysis Chart | MarketScreener

Technical investigation trends 908 DEVICES INC.

Short TermMid-TermLong Term
TrendsNeutralBearishNeutral

Income Statement Evolution

Consensus

Sell

Buy

Mean consensus BUY
Number of Analysts 4
Last Close Price 16,01 $
Average people price 26,50 $
Spread / Average Target 65,5%

EPS Revisions

Managers and Directors

Kevin J. Knopp President, Chief Executive Officer & Director
Joseph H. Griffith Chief Financial Officer
E. Kevin Hrusovsky Chairman
Christopher D. Brown Chief Technology Officer & Vice President
Mark D. Spoto Independent Director

Sector and Competitors

1st jan.Capi. (M$)
908 DEVICES INC.-38.11%506
SARTORIUS AG-29.55%26 914
QUIDELORTHO CORPORATION-30.85%6 165
BIOTAGE AB (PUBL)-27.60%1 205
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.67.33%1 186
REVENIO GROUP OYJ-24.75%1 148

Read Entire Article